JANE STREET GROUP, LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,361,869
-30.9%
55,025
-21.0%
0.00%
-100.0%
Q2 2023$1,971,639
+235.7%
69,620
+172.3%
0.00%
Q1 2023$587,366
-29.6%
25,571
-13.9%
0.00%
Q4 2022$834,425
-25.4%
29,716
-41.1%
0.00%
Q2 2022$1,119,000
-28.0%
50,479
-5.5%
0.00%
Q1 2022$1,555,000
-82.7%
53,438
-80.4%
0.00%
-100.0%
Q4 2021$8,969,000
-26.8%
272,899
+2.7%
0.00%
-25.0%
Q3 2021$12,259,000
-15.1%
265,645
+1.4%
0.00%
-33.3%
Q2 2021$14,432,000
+39.2%
261,875
+30.4%
0.01%0.0%
Q1 2021$10,370,000
-20.0%
200,813
-32.9%
0.01%0.0%
Q4 2020$12,959,000
+111.5%
299,067
+70.8%
0.01%
+100.0%
Q3 2020$6,128,000
-26.6%
175,056
+12.1%
0.00%
-40.0%
Q2 2020$8,349,000
+1362.2%
156,117
+869.7%
0.01%
Q1 2020$571,000
-70.4%
16,100
-60.2%
0.00%
-100.0%
Q4 2019$1,932,000
+355.7%
40,458
+209.5%
0.00%
+200.0%
Q3 2019$424,000
+12.8%
13,071
+134.3%
0.00%0.0%
Q1 2019$376,000
-77.2%
5,578
-74.0%
0.00%
-75.0%
Q3 2018$1,652,000
+80.7%
21,413
+97.3%
0.00%
+100.0%
Q2 2018$914,000
+294.0%
10,852
+141.2%
0.00%
+100.0%
Q2 2017$232,000
-88.3%
4,500
-88.0%
0.00%
-90.0%
Q3 2016$1,982,000
+458.3%
37,527
+329.1%
0.01%
+400.0%
Q1 2016$355,000
+19.9%
8,746
+228.7%
0.00%0.0%
Q2 2015$296,000
-75.3%
2,661
-75.1%
0.00%
-77.8%
Q4 2014$1,198,000
+87.8%
10,692
-23.3%
0.01%
+12.5%
Q2 2014$638,00013,9330.01%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,661,605$61,137,0671.46%
Bellevue Group AG 4,013,500$92,190,0951.34%
Eagle Health Investments LP 267,630$6,147,4611.20%
ARMISTICE CAPITAL, LLC 3,460,000$79,476,2001.14%
Integral Health Asset Management, LLC 213,000$4,892,6100.99%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$10,428,3800.44%
ArrowMark Colorado Holdings LLC 1,557,705$35,780,4840.41%
FARALLON CAPITAL MANAGEMENT LLC 2,092,829$48,072,2820.27%
Virtus ETF Advisers LLC 9,932$228,1380.13%
JACOBS LEVY EQUITY MANAGEMENT, INC 614,533$14,115,8230.09%
View complete list of AGIOS PHARMACEUTICALS INC shareholders